

[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Brian Abrahams Reiterated (XENE) at Buy and Held Target at $55 on, Jun 18th, 2024
Brian Abrahams of RBC Capital, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $55 on, Jun 18th, 2024.
Brian has made no other calls on XENE in the last 4 months.
There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Brian
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $50 on, Friday, May 10th, 2024
- Serge Belanger of "Needham" Maintained at Strong Buy and Held Target at $62 on, Friday, May 10th, 2024
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Wednesday, April 10th, 2024
Contributing Sources